Cargando…
Corrigendum to “A PLK1 kinase inhibitor enhances the chemosensitivity of cisplatin by inducing pyroptosis in oesophageal squamous cell carcinoma” [EBioMedicine 41 (2019) 244–255]
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7804599/ https://www.ncbi.nlm.nih.gov/pubmed/33418498 http://dx.doi.org/10.1016/j.ebiom.2020.103041 |
| _version_ | 1783636188523921408 |
|---|---|
| author | Wu, Mengjiao Wang, Yan Yang, Di Gong, Ying Rao, Feng Liu, Rui Yeerken, Danna Li, Jinting Fan, Jiawen Chen, Jie Zhang, Weimin Zhan, Qimin |
| author_facet | Wu, Mengjiao Wang, Yan Yang, Di Gong, Ying Rao, Feng Liu, Rui Yeerken, Danna Li, Jinting Fan, Jiawen Chen, Jie Zhang, Weimin Zhan, Qimin |
| author_sort | Wu, Mengjiao |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7804599 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78045992021-01-22 Corrigendum to “A PLK1 kinase inhibitor enhances the chemosensitivity of cisplatin by inducing pyroptosis in oesophageal squamous cell carcinoma” [EBioMedicine 41 (2019) 244–255] Wu, Mengjiao Wang, Yan Yang, Di Gong, Ying Rao, Feng Liu, Rui Yeerken, Danna Li, Jinting Fan, Jiawen Chen, Jie Zhang, Weimin Zhan, Qimin EBioMedicine Corrigendum Elsevier 2021-01-06 /pmc/articles/PMC7804599/ /pubmed/33418498 http://dx.doi.org/10.1016/j.ebiom.2020.103041 Text en © 2020 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Corrigendum Wu, Mengjiao Wang, Yan Yang, Di Gong, Ying Rao, Feng Liu, Rui Yeerken, Danna Li, Jinting Fan, Jiawen Chen, Jie Zhang, Weimin Zhan, Qimin Corrigendum to “A PLK1 kinase inhibitor enhances the chemosensitivity of cisplatin by inducing pyroptosis in oesophageal squamous cell carcinoma” [EBioMedicine 41 (2019) 244–255] |
| title | Corrigendum to “A PLK1 kinase inhibitor enhances the chemosensitivity of cisplatin by inducing pyroptosis in oesophageal squamous cell carcinoma” [EBioMedicine 41 (2019) 244–255] |
| title_full | Corrigendum to “A PLK1 kinase inhibitor enhances the chemosensitivity of cisplatin by inducing pyroptosis in oesophageal squamous cell carcinoma” [EBioMedicine 41 (2019) 244–255] |
| title_fullStr | Corrigendum to “A PLK1 kinase inhibitor enhances the chemosensitivity of cisplatin by inducing pyroptosis in oesophageal squamous cell carcinoma” [EBioMedicine 41 (2019) 244–255] |
| title_full_unstemmed | Corrigendum to “A PLK1 kinase inhibitor enhances the chemosensitivity of cisplatin by inducing pyroptosis in oesophageal squamous cell carcinoma” [EBioMedicine 41 (2019) 244–255] |
| title_short | Corrigendum to “A PLK1 kinase inhibitor enhances the chemosensitivity of cisplatin by inducing pyroptosis in oesophageal squamous cell carcinoma” [EBioMedicine 41 (2019) 244–255] |
| title_sort | corrigendum to “a plk1 kinase inhibitor enhances the chemosensitivity of cisplatin by inducing pyroptosis in oesophageal squamous cell carcinoma” [ebiomedicine 41 (2019) 244–255] |
| topic | Corrigendum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7804599/ https://www.ncbi.nlm.nih.gov/pubmed/33418498 http://dx.doi.org/10.1016/j.ebiom.2020.103041 |
| work_keys_str_mv | AT wumengjiao corrigendumtoaplk1kinaseinhibitorenhancesthechemosensitivityofcisplatinbyinducingpyroptosisinoesophagealsquamouscellcarcinomaebiomedicine412019244255 AT wangyan corrigendumtoaplk1kinaseinhibitorenhancesthechemosensitivityofcisplatinbyinducingpyroptosisinoesophagealsquamouscellcarcinomaebiomedicine412019244255 AT yangdi corrigendumtoaplk1kinaseinhibitorenhancesthechemosensitivityofcisplatinbyinducingpyroptosisinoesophagealsquamouscellcarcinomaebiomedicine412019244255 AT gongying corrigendumtoaplk1kinaseinhibitorenhancesthechemosensitivityofcisplatinbyinducingpyroptosisinoesophagealsquamouscellcarcinomaebiomedicine412019244255 AT raofeng corrigendumtoaplk1kinaseinhibitorenhancesthechemosensitivityofcisplatinbyinducingpyroptosisinoesophagealsquamouscellcarcinomaebiomedicine412019244255 AT liurui corrigendumtoaplk1kinaseinhibitorenhancesthechemosensitivityofcisplatinbyinducingpyroptosisinoesophagealsquamouscellcarcinomaebiomedicine412019244255 AT yeerkendanna corrigendumtoaplk1kinaseinhibitorenhancesthechemosensitivityofcisplatinbyinducingpyroptosisinoesophagealsquamouscellcarcinomaebiomedicine412019244255 AT lijinting corrigendumtoaplk1kinaseinhibitorenhancesthechemosensitivityofcisplatinbyinducingpyroptosisinoesophagealsquamouscellcarcinomaebiomedicine412019244255 AT fanjiawen corrigendumtoaplk1kinaseinhibitorenhancesthechemosensitivityofcisplatinbyinducingpyroptosisinoesophagealsquamouscellcarcinomaebiomedicine412019244255 AT chenjie corrigendumtoaplk1kinaseinhibitorenhancesthechemosensitivityofcisplatinbyinducingpyroptosisinoesophagealsquamouscellcarcinomaebiomedicine412019244255 AT zhangweimin corrigendumtoaplk1kinaseinhibitorenhancesthechemosensitivityofcisplatinbyinducingpyroptosisinoesophagealsquamouscellcarcinomaebiomedicine412019244255 AT zhanqimin corrigendumtoaplk1kinaseinhibitorenhancesthechemosensitivityofcisplatinbyinducingpyroptosisinoesophagealsquamouscellcarcinomaebiomedicine412019244255 |